Day: May 16, 2023

SAN FRANCISCO, May 16, 2023 (GLOBE NEWSWIRE) — Owler, a Meltwater offering and the world’s most comprehensive community-powered business data and intelligence platform, today has launched a new feature to its sales intelligence solution Owler Max – Contact Data. This feature will provide its subscribers with direct access to reliable contact information of decision-makers of North American companies, making their prospecting journey more seamless and effective.

With over 15 million companies in its database, Owler has been a go-to resource for sales teams to gather insights on companies, their competitors, funding, and leadership changes. Now with Contact Data, sales teams can easily uncover direct phone numbers, email addresses, and LinkedIn profiles of key contacts within an organization in a matter of seconds.

The new feature has been launched in response to the growing demand of sales teams who are constantly looking for ways to enhance their outreach efforts. Owler’s Contact Data feature has been designed to help sales teams save time and optimize their sales process by providing them with the necessary contact details of the decision-makers they are targeting.

Tim Harsch, CEO of Owler said, ‘We are very excited to introduce Contact Data into our Owler Max tool, This is a powerful way to get in touch with potential customers and partners. Our goal has always been to make it easier for companies to grow and succeed, and this new addition to our platform will help our users do just that.”

This latest addition to Owler Max’s suite of tools is also an indication of the company’s continued commitment to innovation and providing our subscribers with the most cutting-edge tools and resources available. Owler Max, with the new Contact Data feature, is poised to become an even more essential tool for businesses looking to expand their reach and boost sales.

Founded in 2011 and acquired by Meltwater in 2021, Owler is the largest crowdsourced company data provider. Owler datasets are proprietary and sourced first-hand, powered by a community of over 5 million global business professionals representing an active business community. Owler Max’s fresh, accurate and exclusive data, not found on any competitor platforms, eliminates time-consuming additional research.

To learn more about Owler Max or schedule a demo, please visit https://corp.owler.com/owlermax.

About Owler

Owler, a Meltwater offering, is the world’s largest community-driven business information and insights platform. Owler provides exclusive firmographic and competitive data on over 15 million private and public businesses, curated from a community of 5 million business professionals. Owler helps professionals outsmart their competition with actionable insights and real-time alerts about the companies that matter to them. To learn more, visit corp.owler.com, call the US number at 1-650-242-9253, or email support at support@owler.com.

Press contact: 
pr@meltwater.com

GlobeNewswire Distribution ID 8840849

Strategic collaboration supports BEEAH in creating Jawaher Boston Medical District in Sharjah, United Arab Emirates

Boston, MA, May 16, 2023 (GLOBE NEWSWIRE) — Mass General Brigham and Dana-Farber Cancer Institute are collaborating with BEEAH Group, an organization pioneering sustainability and quality of life solutions in the Middle East, to advise in the development of the Jawaher Boston Medical District, a state-of-the-art health care system designed to deliver world-class, patient-centered care through innovation, technology, and sustainability. Mass General Brigham and Dana-Farber Cancer Institute are strategic partners, serving in an advisory capacity, on the project in Sharjah, United Arab Emirates, which includes a multi-specialty flagship hospital for integrated, cutting-edge care.

The collaboration combines the depth and breadth of clinical expertise and innovation from Mass General Brigham and Dana-Farber Cancer Institute, with BEEAH’s vision to create a sustainable, advanced, patient-centered health system designed to deliver care to patients within – and beyond – hospital walls. BEEAH Group was founded in 2007 to tackle sustainability challenges in Sharjah and improve quality of life.

Focused on serving the unique needs of the people of Sharjah and the region, the Jawaher Boston Medical District will offer patients access to the latest clinical expertise across a wide variety of integrated clinical specialties, including lifestyle medicine and prevention, oncology, women’s health, pediatrics, cardiovascular, neurosciences, behavioral health, and rehabilitation medicine. In addition to medical and research expertise, Mass General Brigham and Dana-Farber Cancer Institute will also collaborate with BEEAH Group to advise on best practices in workforce training, development, and public education to the community, with attention to developing local talent.

Mass General Brigham and Dana-Farber Cancer Institute are advising BEEAH Group in their development of multiple facilities, comprising the flagship hospital and ambulatory clinics across Sharjah, with integrated, innovative, and digital solutions, including app-based care and hospital-at-home.

“Mass General Brigham has a deep history of global collaboration aimed at serving and improving the lives of patients around the world,” said Raymond W. Liu, MD, Vice President, Mass General Brigham Global Advisory.  “In collaborating with BEEAH, we hope to contribute our decades of expertise to their development of a unique, innovative vision for a health system that builds on medicine’s leading edge, with an eye to the future.”

“Dana-Farber, a world leader in cancer treatment and research, is committed to advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases locally and globally,” said Adam Reich, Vice President of Business Initiatives at Dana-Farber Cancer Institute. “We are pleased to work with BEEAH and extend our expertise to this collaboration as part of our mission to enhance access to expert cancer care and reduce the burden of cancer worldwide.”

By leveraging its expertise in quality-of-life solutions in Sharjah and the Middle East, BEEAH will create a new destination for the health, wellness and quality of life for the people of Sharjah and the region focused on patient outcomes and experience gleaned from a robust academic ecosystem pioneered, developed and refined over two centuries by Mass General Brigham and Dana-Farber Cancer Institute clinicians.

By pooling their combined medical, research and sustainability expertise, Mass General Brigham, Dana-Farber Cancer Institute and BEEAH will develop innovative technologies, diagnostics, delivery models and patient care, ultimately fostering research, directly benefitting patients globally and providing valuable cross-institutional learnings in the United States. The outcome will enable BEEAH to create a comprehensive patient-centered health care system for the people of Sharjah and the UAE, integrating healthcare solutions into homes, schools, workplaces, and communities to help all patients and their families live healthier lives.

“By partnering with Mass General Brigham and Dana-Farber Cancer Institute, BEEAH Group is entering the healthcare industry and adding a new dimension to our purpose of pioneering a sustainable quality of life for the people of Sharjah, the UAE, and beyond,” said Khaled Al Huraimel, Group CEO of BEEAH Group. “Drawing from the expertise of our partners in Boston, we look forward to creating not just an integrated health network, but a future-ready healthcare ecosystem. The Jawaher Boston Medical District will provide patients in Sharjah access to world-class healthcare closer to home, while also serving as a hub for the development of cutting-edge treatments and medical advancement.”

The project draws from Mass General Brigham and Dana-Farber Cancer Institute’s medical and research expertise, as well as BEEAH Group’s experience collaborating and innovating with international partners to create facilities that are sustainable, digitally-enabled and centered around the comfort and convenience of occupants.

Following a meeting of representatives from Mass General Brigham, Dana-Farber Cancer Institute and BEEAH Group, Sheikha Jawaher Al Qasimi, Wife of the Ruler of Sharjah and Chairperson of BEEAH Group, and Meghan Gregonis, United States General Consul in Dubai, the Jawaher Boston Medical District in Sharjah was approved to move forward.

About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit www.massgeneralbrigham.org.

About Dana-Farber Cancer Institute 
Dana-Farber Cancer Institute is one of the world’s leading centers of cancer research and treatment. Dana-Farber’s mission is to reduce the burden of cancer through scientific inquiry, clinical care, education, community engagement, and advocacy. Dana-Farber is a federally designated Comprehensive Cancer Center and a teaching affiliate of Harvard Medical School.

We provide the latest treatments in cancer for adults through Dana-Farber Brigham Cancer Center and for children through Dana-Farber is the only hospital with a top 4 U.S. News & World Report Best Cancer Hospital ranking in both adult and pediatric care.

As a global leader in oncology, Dana-Farber is dedicated to a unique and equal balance between cancer research and care, translating the results of discovery into new treatments for patients locally and around the world, offering more than 1,100 clinical trials.

For more information, please visit www.dana-farber.org.

About BEEAH Group
BEEAH Group is the region’s leading sustainability and digitalisation expert, renowned for ground-breaking environmental innovations and smart solutions for future-ready cities. Recognising sustainability and technology as the pillars of a modern economy, BEEAH Group has invested in a comprehensive, full-circle strategy for the future. BEEAH Group operates in the industries of waste management, renewable energy, technology, consulting, education, transport, real estate and healthcare. Raising the bar for the quality of life in the region, BEEAH Group businesses continue to set industry benchmarks in sustainable, smart solutions and help countries across the region create and execute their roadmap for a socially responsible future. The Group currently operates in the UAE, Egypt and KSA. For more information, please visit www.beeahgroup.com and connect on LinkedIn, Instagram, Facebook and Twitter @beeahgroup

Noah Brown
Mass General Brigham
617-643-3907
Nbrown9@mgb.org

GlobeNewswire Distribution ID 8840712

HqO is the world’s leading workplace experience platform; Savills is the largest tenant-focused advisory firm in North America

BOSTON, May 16, 2023 (GLOBE NEWSWIRE) —  HqO, the world’s leading workplace experience platform, today announced a strategic partnership with Savills, North America’s largest tenant-focused advisory firm. The partnership will enable Savills to provide its clients the ability to demonstrate the value of real estate through unique, actionable insights into connecting with and empowering employees, increasing flexibility in the workplace, and reimagining how the modern workplace enhances productivity and community.

HqO and Savills – both renowned for their steadfast commitment to advocating for occupiers across the globe, as well as for their cutting-edge technology, market data, and workplace insights – formed the alliance in an effort to best advise corporates navigating a real estate ecosystem that is currently experiencing a generational disruption.

“Savills modern and differentiated approach to translating data and market intelligence into actionable insights for occupiers across the globe, coupled with HqO’s position as a proven leader in the tenant experience space, makes this strategic alliance mutually beneficial for both parties,” said Sarah Dreyer, Executive Vice President, Information, Technology and Digital Strategy at Savills.

Due to the firms’ respective areas of expertise, the partnership will allow Savills and HqO to empirically demonstrate which layouts, amenities, and workplace programs drive employee engagement and maximize the ROI of every dollar spent on office space.

The partnership will provide granular visibility into how employees experience and interact with their workplace. In turn, corporate leaders will be able to evaluate and optimize their office performance to reimagine a modern workplace that enhances productivity, promotes community, and energizes employees.

“The last three years have radically transformed how people connect with each other and the places they work. Being able to activate those trends from users to physical real estate properties is mission-critical today,” said Chase Garbarino, Co-Founder and CEO at HqO. “Savills shares the same vision as HqO, and the overall belief that the future of the workplace will be driven by their experiences. This partnership represents the significant shift in overall mindset towards customer-centricity for the first time in the larger commercial real estate industry.”

About Savills Inc.:
Savills helps organizations find the right solutions that ensure employee success. Sharply skilled and fiercely dedicated, the firm’s integrated teams of consultants and brokers are experts in better real estate. With services in tenant representation, workforce and incentives strategy, workplace strategy and occupant experience, project management, and capital markets, Savills has elevated the potential of workplaces around the corner, and around the world, for 160 years and counting. For more information, please visit Savills.us.

About HqO:
HqO, ranked No. 75 on the Inc. 5000 list, is transforming how people connect with each other and the places they work. The HqO Workplace Experience Platform makes it easy for companies and commercial property teams to create modern workplaces through world-class amenities and services that allow people to thrive and produce the best results. Active in over 250 million square feet in 25 countries, 57% of the Fortune 100 rely on HqO to enhance their workplace experiences, improve employee satisfaction, and drive operational excellence. For more information, visit www.hqo.com.

For additional questions or more information, please reach out to HqOPR@boathouseinc.com.

GlobeNewswire Distribution ID 8840030

May 16, 2023

Late-breaking data from DCR4Contrast study presented at EuroPCR 2023 and SCAI 2023 also shows an average reduction in the total number of angiograms obtained during each procedure of 26.3% [1]

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced late-breaking data from the DCR4Contrast (Dynamic Coronary Roadmap for Contrast Reduction) trial, the largest ever randomized controlled multicenter clinical trial to investigate the ability of Philips Dynamic Coronary Roadmap (DCR) to reduce the total iodinated contrast media volumes administered during percutaneous coronary intervention (PCI) procedures, compared to PCI performed without DCR guidance. The results were presented today at the European Association of Percutaneous Cardiovascular Interventions (EuroPCR) 2023 course and will also be presented later this week at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 scientific sessions.

The number of high-risk patients undergoing PCI procedures worldwide has increased significantly [2]. Iodine contrast media is used to visualize the coronary arteries during PCI procedures, but it can potentially harm the kidneys, risking the development of contrast-induced acute kidney injury (CI-AKI) after the procedure. The study found that Dynamic Coronary Roadmap reduced the total iodine contrast volume per procedure on average by 28.8% (95% Confidence Interval: 18.9%, 38.2%), and reduced the number of angiograms per procedure on average by three runs based on a procedure with an average of 11 runs or 26.3% reduction (95% Confidence Interval: 16.8%, 35.1%) [1].

“Enabling physicians to decrease contrast administration during procedures with tools like DCR could make a significant contribution to both the safety and quality of PCI. This is important at a time when PCI is increasingly used in patients with a complex clinical or anatomical profile,” said Prof. Javier Escaned, MD, Head of the Interventional Cardiology Section at Hospital Clinico San Carlos, Madrid Spain, who presented the results today during a late-breaking session at the annual meeting for the EuroPCR 2023 (May 16-19, Paris, France).

“At Philips, we are committed to championing technologies that improve the patient’s experience, improve their safety and expand access to procedures to new patient groups. Dynamic Coronary Roadmap helps achieve these goals by structurally reducing the amount of contrast agent required for PCI procedures,” said Dr. Atul Gupta, Chief Medical Officer for Image Guided Therapy at Philips.

Multi-center, prospective, unblinded, stratified, 1:1 randomized controlled trial
The DCR4Contrast trial ran from November 2019 to February 2023 across hospitals in the U.S., Europe and Israel. In total, 371 patients were randomized and stratified within both ad hoc and planned PCI, according to the number of vessels to be treated. Patients in the DCR group underwent PCI procedures where DCR was used to guide coronary wires, balloons, stents and other PCI diagnostic or therapeutic devices. Patients assigned to the control group underwent PCI without DCR support, following the current standard of care [1].

On Thursday, May 18 Professor John C. Messenger, MD, University of Colorado School of Medicine and Director of the Cardiac Catheterization Laboratories and Cardiovascular ICU at the University of Colorado Hospital will present the data at the Society for Cardiovascular Angiography & Interventions (SCAI): “These results are very exciting,” Professor Messenger commented. “They confirm that Philips Dynamic Coronary Roadmap can be applied to all PCIs and has the potential to increase overall PCI safety by mitigating one of the few preventable contributors (iodinated contrast media use) to contrast-induced acute kidney injury following PCI.” More information on Professor Messenger’s presentation at SCAI can be found here.

Philips’ Dynamic Coronary Roadmap software is a real-time visualization innovation that removes the need for additional contrast media injections by overlaying the angiogram onto real-time motion-compensated 2D fluoroscopic imaging to provide interventionalists with continuous visual feedback on the positioning of guide wires and catheters. Complementing this technology, the Philips IntraSight precision guidance system streamlines lesion assessment, simplifies vessel sizing, enables precise therapy delivery and also supports the operator in their goal to reduce contrast volumes.

[1] Study reference number DHF287327
[2] Waldo SW, Gokhale M, O’Donnell CI, Plomondon ME, Valle JA, Armstrong EJ, Schofield R, Fihn SD, Maddox TM. Temporal Trends in Coronary Angiography and Percutaneous Coronary Intervention: Insights From the VA Clinical Assessment, Reporting, and Tracking Program. JACC Cardiovasc Interv 2018;11:879–888.

For further information, please contact:

Joost Maltha
Philips Global Press Office
Tel: +31 6 10 55 8116
Email: joost.maltha@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

• Philips Dynamic Coronary Roadmap
• Philips Azurion

GlobeNewswire Distribution ID 1000810107